US intelligence officials reported that in late February, they told the senators who participated in the biotechnology security bill drafted. Chinese Pharmaceutical Company Yao Kangde passed US customer data to China without consent.
Reuters on Thursday (March 28) quoted anonymous sources that the FBI held a confidential briefing for about a dozen senators.These officials refer to the activities that violate the national security interests in the United States in the United States.
Sources said that one of the concerns of these institutions is that Yao Ming Kangde passed the intellectual property of an American customer to China without consent.This involves Yaoming Kant's information appeared in recent intelligence.Sources did not say the name of the customer.
A spokesman for Yaoming Kant said that they do not know the company's situation of transferring data or intellectual property rights to any American customers without authorization, and emphasized that protecting customer information is very important to the company.The company stores the information according to the customer's instructions (in Keeping with their Direction).Yaoming Kant respects and fully abides by the requirements of the Federal and State Government.
The FBI, the Office of the National Intelligence Director, and the US State Department refused to comment.
After Reuters reported this news in the afternoon, the stock price of Yaoming Kangde Hong Kong stocks increased from more than 4%in the afternoon, which narrowed at least 1%. As of 3.47 pm, it only rose slightly by 0.54%.
The U.S. government is worried that some Chinese biotechnology companies are contributing to technology or R & D projects for the use of the Chinese military, and the proposed biotechnology security bill will restrict the US government with funds to these Chinese companies.
